AtaCor Medical

The AtaCor EV Temporary Pacing System is designed to enable reliable, prompt, imaging-free temporary pacing with safe post-procedure ambulation.

[AtaCor Medical @AtaCorMedical]

“The cardiac notch is the perfect location for an EV-ICD lead insertion” Shephal Doshi MD at #hrs2024. Excellent presentation on the #AtaCor #EVICD system. 100% implant success, a 9 minute median time to implant, and 95% defibrillation success with left pectoral ICD placement!

[AtaCor Medical @AtaCorMedical]

Day Two at HRS! Check out today’s AtaCor abstract presentation by Dr. Shephal Doshi at 3:30 in the New CIED Technologies: What’s on the Horizon session. #HRS2024 #epeeps

[AtaCor Medical @AtaCorMedical]

Excellent presentation yesterday from Martin Burke on the AtaCor EV solutions at the Stanford Biodesign Arrhythmia Retreat. Exciting to be a part of this meeting highlighting the latest innovations in electrophysiology. #epeeps #HRS2024 #AtaCor

[AtaCor Medical @AtaCorMedical]

Wrap up #HRS24 on Sunday, May 19 with two additional AtaCor scientific sessions. Add these sessions to your HRS planner today and see you in Boston! #HRS2024 #epeeps https://t.co/hzKi89kBYG

[AtaCor Medical @AtaCorMedical]

Another AtaCor Scientific Session at HRS on Saturday, May 18! Join us to learn more about our novel EV-ICD lead system. Stay outside of the vascular system! #HRS2024 #HRS24 #epeeps https://t.co/hzKi89k498

[AtaCor Medical @AtaCorMedical]

Join us Wed May 15 in Boston at the Stanford Biodesign New Arrhythmia Technologies Retreat where over 60 international thought leaders and innovators will discuss emerging technologies, including AtaCor's solutions! Register today https://t.co/FQ08oE985d #epeeps #HRS2024

[AtaCor Medical @AtaCorMedical]

#HRS2024 is right around the corner. AtaCor’s EV-ICD and EV temporary pacing lead systems will be featured in several abstract presentations throughout the event! Mark your calendars to join us for these presentations! #epeeps https://t.co/hzKi89k498

[AtaCor Medical @AtaCorMedical]

We are excited to announce that we have successfully closed $28M in our Series C financing round!! Congrats to the entire #AtaCor team on this important milestone! Read the full announcement here. https://t.co/XdthUZv7y3
#cardiology #CRM #EVICD

[AtaCor Medical @AtaCorMedical]

AtaCor Medical completes enrollment in its initial acute extravascular ICD study, designed to evaluate delivery of a novel EV-ICD lead and defibrillation success when connected to commercially available ICD systems.

https://t.co/fIE6xSsyoB

[AtaCor Medical @AtaCorMedical]

AtaCor Medical took home the “Deal of the Year” award at the @OctaneOC #HighTechAwards ceremony on Thursday, September 23. The reception was held at the Balboa Bay Resort in Newport Beach, CA.

[AtaCor Medical @AtaCorMedical]

Following a successful $25M round of financing, AtaCor Medical has been chosen as a finalist in the 27th annual @OctaneOC #HighTechAwards in the “Deal of the Year” category. Winners will be announced at the award ceremony Thursday, September 23 in Newport Beach.

[AtaCor Medical @AtaCorMedical]

Join us at Heart Rhythm Society 2021 July 28-31 in Boston as Dr. Martin Burke presents new data to support the use of an entirely extracardiac temporary pacing lead system.
#HeartRhythmSociety #ExtracardiacPacing #AtaCorMedical #TemporaryPacing

[AtaCor Medical @AtaCorMedical]

Advancing the Standard of #CardiacPacing:
$25M Series B financing secured to support development of a novel #ExtracardiacPacing system designed to leave the heart completely untouched—for prompt pacing without the drawbacks of traditional methods:
https://t.co/vbuhyBTH2b

[AtaCor Medical @AtaCorMedical]

Dr. Anne-Floor Quast presenting development data for AtaCor's extracardiac pacing system. Pacing without touching the heart is feasible and may offer an important new option for patients requiring temporary and/or permanent pacing therapy.

#HRS2019 #atacormedical

[AtaCor Medical @AtaCorMedical]

@goranm @OCTANeOC Thanks @goranm. Grateful to be a part of the @OCTANeOC LaunchPad program this year!

[AtaCor Medical @AtaCorMedical]

Cardiac pacing without touching the heart... AtaCor Medical announces completion of a $8.8M Series A financing to support development of its novel, extravascular substernal cardiac pacing system. https://t.co/tS31OMju2U

[AtaCor Medical @AtaCorMedical]

AtaCor posters upcoming this afternoon at HRS #HRS2018

[AtaCor Medical @AtaCorMedical]

Excited to share new data tomorrow at HRS! #HRS2018 #atacormedical